BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 14517210)

  • 1. Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts.
    Sowa H; Kaji H; Iu MF; Tsukamoto T; Sugimoto T; Chihara K
    J Biol Chem; 2003 Dec; 278(52):52240-52. PubMed ID: 14517210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.
    Tobimatsu T; Kaji H; Sowa H; Naito J; Canaff L; Hendy GN; Sugimoto T; Chihara K
    Endocrinology; 2006 May; 147(5):2583-90. PubMed ID: 16484320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells.
    Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
    J Biol Chem; 2002 Sep; 277(39):36024-31. PubMed ID: 12130649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppresses Smad3 pathway in osteoblastic cells.
    Iu MF; Kaji H; Sowa H; Naito J; Sugimoto T; Chihara K
    J Endocrinol; 2005 Apr; 185(1):131-8. PubMed ID: 15817834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
    Kwok S; Qin L; Partridge NC; Selvamurugan N
    J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
    Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
    J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
    Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling.
    Qiao B; Padilla SR; Benya PD
    J Biol Chem; 2005 Apr; 280(17):17562-71. PubMed ID: 15743758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells.
    Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
    J Bone Miner Res; 2002 Jul; 17(7):1190-9. PubMed ID: 12096832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway.
    Hisa I; Inoue Y; Hendy GN; Canaff L; Kitazawa R; Kitazawa S; Komori T; Sugimoto T; Seino S; Kaji H
    J Biol Chem; 2011 Mar; 286(11):9787-96. PubMed ID: 21239498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells.
    Reppe S; Olstad OK; Rian E; Gautvik VT; Gautvik KM; Jemtland R
    Biochem Biophys Res Commun; 2004 Nov; 324(1):218-23. PubMed ID: 15465005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
    Costamagna E; GarcĂ­a B; Santisteban P
    J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation.
    Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D
    J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.
    Bellido T; Ali AA; Plotkin LI; Fu Q; Gubrij I; Roberson PK; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
    J Biol Chem; 2003 Dec; 278(50):50259-72. PubMed ID: 14523023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
    Palcy S; Bolivar I; Goltzman D
    J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
    Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
    J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.